3Beta-Hydroxysteroid dehydrogenase/delta 4-5 isomerase (3-HSD/isomerase), a rate-limiting enzyme complex found in most steroid-metabolizing tissues, has not been purified from human placenta where it is equally distributed between the mitochondria and microsomes. The enzyme activities were co-solubilized from mitochondria using sodium deoxycholate (Edwards et al., 1976). Preliminary data is presented in this proposal that Brij 58 treatment of placental microsomes co-solubilizes 3-HSD and isomerase. The applicant proposes to purify solubilized 3-HSD/isomerase from both organelles by ammonium sulfate precipitation, affinity chromatography, and gel filtration chromatography. Should the 3-HSD and isomerase activities separate, 3-HSD activity will be followed. Purified enzyme homogeneity will be demonstrated: single band on SDS and non-denaturing polyacrylamide electrophoresis; single NH2-terminus; non-specific antibody formation by immunization of rabbits. 3-HSD/isomerase purified from microsomes and mitochondria will be separately characterized: molecular weight; subunit composition; amino acid composition; NH2-terminus sequence; stability in solution; pH and temperature optimums; substrate and cofactor kinetic profile; and product inhibition kinetic studies. These observations will demonstrate the degree of similarity between the mitochondrial and microsomal enzymes. To address whether pregnene and androstene substrates are oxidized at the same active site and whether the 3-HSD and isomerase activities reside at the same or separate centers on the purified protein, affinity alkylation and radioalkylation studies are proposed. Affinity alkylating analogs of substrate (pregnenolone, dehydroepiandrosterone), product (progesterone, androstenedione), and inhibitor (estrone, equilenin) steroids; an enzyme-generated affinity alkylator (estryne); and alkylating cofactor analogs (eg: fluorosulfonylbenzoyladenosine) will be used. The profiles from enzyme inactivation, substrate and cofactor protection from inactivation, and amino acids radioalkylated should answer these questions regarding the multiple activities of 3-HSD/isomerase. If dehydroepiandrosterone of fetal origin and maternal pregnenolone are oxidized at the same site, the fetus can induce """"""""progesterone withdrawal"""""""" via 3-HSD allowing prostaglandin-mediated myometrial contractions. Purification and study of 3-HSD/isomerase will clarify both the importance of this enzyme in the cascade of events which initiate labor and steroid metabolism at a macromolecular binding site.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD020055-02
Application #
3317864
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1985-08-01
Project End
1988-07-31
Budget Start
1986-08-01
Budget End
1987-07-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Thomas, James L; Duax, William L; Addlagatta, Anthony et al. (2004) Structure/function aspects of human 3beta-hydroxysteroid dehydrogenase. Mol Cell Endocrinol 215:73-82
Thomas, James L; Umland, Timothy C; Scaccia, Launa A et al. (2004) The higher affinity of human type 1 3beta-hydroxysteroid dehydrogenase (3beta-HSD1) for substrate and inhibitor steroids relative to human 3beta-HSD2 is validated in MCF-7 tumor cells and related to subunit interactions. Endocr Res 30:935-41
Thomas, James L; Duax, William L; Addlagatta, Anthony et al. (2003) Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1 3 beta-hydroxysteroid dehydrogenase/isomerase. J Biol Chem 278:35483-90
Thomas, James L; Mason, J Ian; Brandt, Stacey et al. (2002) Structure/function relationships responsible for the kinetic differences between human type 1 and type 2 3beta-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity. J Biol Chem 277:42795-801
Thomas, James L; Mason, J Ian; Brandt, Stacey et al. (2002) Differences in substrate and inhibitor kinetics of human type 1 and type 2 3beta-hydroxysteroid dehydrogenase are explained by the type 1 mutant, H156Y. Endocr Res 28:471-5
Thomas, J L; Mason, J I; Blanco, G et al. (2001) The engineered, cytosolic form of human type I 3beta-hydroxysteroid dehydrogenase/isomerase: purification, characterization and crystallization. J Mol Endocrinol 27:77-83
Mason, J I; Naville, D; Evans, B W et al. (1998) Functional activity of 3beta-hydroxysteroid dehydrogenase/isomerase. Endocr Res 24:549-57
Thomas, J L; Evans, B W; Blanco, G et al. (1998) Site-directed mutagenesis identifies amino acid residues associated with the dehydrogenase and isomerase activities of human type I (placental) 3beta-hydroxysteroid dehydrogenase/isomerase. J Steroid Biochem Mol Biol 66:327-34
Thomas, J L; Evans, B W; Strickler, R C (1997) Affinity radiolabeling identifies peptides associated with the isomerase activity of human type I (placental) 3beta-hydroxysteroid dehydrogenase/isomerase. Biochemistry 36:9029-34
Thomas, J L; Nash, W E; Strickler, R C (1996) Physiological 3 beta-hydroxy-5-ene steroid substrates bind to 3 beta-hydroxysteroid dehydrogenase without the prior binding of cofactor. J Steroid Biochem Mol Biol 58:211-6

Showing the most recent 10 out of 24 publications